Effects of Pilates Method and Aerobic Training in Hypertensive Subjects

April 29, 2020 updated by: Prof. Dr. Antônio Marcos Vargas da Silva, Universidade Federal de Santa Maria

Effects of Pilates Method and Aerobic Training in Hypertensive Subjects: a Randomized Trial

This study evaluates the effects of Pilates method and aerobic training in hypertensive subjects. Half of participants will be trained with Pilates, while the other half will be trained with aerobic exercise during 8 weeks.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • RS
      • Santa Maria, RS, Brazil, 97.105-900
        • University Federal of Santa Maria

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • subjects with high blood pressure controled by medication;
  • sedentary.

Exclusion Criteria:

  • IMC≥30 kg/m²
  • using beta blockers
  • smokers or that interrupted the routine less than 6 months
  • musculoskeletal diseases in evolution or with current symptomatic
  • rheumatological diseases
  • other cardiovascular disease
  • renal disease due to hypertension
  • endocrine, neurological, oncological, immunological, hematological and psychiatric diseases.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Pilates method group
The participants will do Mat Pilates.
1 hour of Mat Pilates, 2 times a week, during 8 weeks.
Other Names:
  • Pilates method
  • Mat Pilates
ACTIVE_COMPARATOR: Aerobic training group
The participants will do aerobic exercise on treadmill.
1 hour of aerobic training on a treadmill, 3 times a week, during 8 weeks.
Other Names:
  • aerobic training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline casual systolic blood pressure at 8 weeks
Time Frame: baseline and 8 weeks
It will be evaluated with oscillometric method of measuring blood pressure with an automated cuff.
baseline and 8 weeks
Change from baseline 24-hour systolic blood pressure at 8 weeks
Time Frame: baseline and 8 weeks
It will be evaluated by 24-hour ambulatory BP monitoring (ABPM)
baseline and 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Casual diastolic blood pressure
Time Frame: baseline and 8 weeks
It will be evaluated with oscillometric method of measuring blood pressure with an automated cuff.
baseline and 8 weeks
Heart rate variability
Time Frame: baseline and 8 weeks
It will be evaluated using a previously validated heart rate monitor Polar 810i, and the results will be analyzed in time- and frequency-domains.
baseline and 8 weeks
Diastolic and mean blood pressure
Time Frame: baseline and 8 weeks
It will be evaluated by 24-hour ambulatory BP monitoring (ABPM)
baseline and 8 weeks
Functional capacity
Time Frame: baseline and 8 weeks
Evaluate by Six-Minute Walk Test (6MWT)
baseline and 8 weeks
Respiratory muscle strength
Time Frame: baseline and 8 weeks
The maximal inspiratory and expiratory pressures will be evaluated with manovacuometer
baseline and 8 weeks
Muscle strength
Time Frame: baseline and 8 weeks
The muscles (quadriceps, gastrocnemius, abdominal and spine extensors) will be evaluated with dynamometer.
baseline and 8 weeks
Flexibility
Time Frame: baseline and 8 weeks
It will be evaluated by bank of Wells test.
baseline and 8 weeks
Body Mass Index
Time Frame: baseline and 8 weeks
It will be calculated as weight (kg) divided by height squared.
baseline and 8 weeks
Oxidative damage
Time Frame: baseline and 8 weeks
It will be evaluated by advanced oxidation protein products (AOPP)
baseline and 8 weeks
Antioxidant capacity
Time Frame: baseline and 8 weeks
It will be evaluated by total antioxidant capacity (TAC).
baseline and 8 weeks
Lipid profile
Time Frame: baseline and 8 weeks
By blood analysis (LDL, HDL, total cholesterol, glucose and triglycerides).
baseline and 8 weeks
Endothelial function
Time Frame: baseline and 8 weeks
By blood analysis (Nitrite measurement/NOx).
baseline and 8 weeks
Inflammation
Time Frame: baseline and 8 weeks
It will be evaluated by C-reactive protein in blood analysis
baseline and 8 weeks
Creatinine
Time Frame: baseline and 8 weeks
By blood analysis
baseline and 8 weeks
Lactate
Time Frame: baselina and 8 weeks
By blood analysis
baselina and 8 weeks
Creatine kinase
Time Frame: baseline and 8 weeks
By blood analysis
baseline and 8 weeks
Questionnaire of Quality of life
Time Frame: baseline and 8 weeks
It will be evaluated by Mini-questionnaire of Quality of Life in Hypertension (MINICHAL)
baseline and 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 20, 2017

Primary Completion (ACTUAL)

May 30, 2018

Study Completion (ACTUAL)

August 31, 2018

Study Registration Dates

First Submitted

July 3, 2017

First Submitted That Met QC Criteria

July 9, 2017

First Posted (ACTUAL)

July 11, 2017

Study Record Updates

Last Update Posted (ACTUAL)

May 1, 2020

Last Update Submitted That Met QC Criteria

April 29, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EPMAT

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Pilates

3
Subscribe